Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Close To Finalizing Revised GMP And Inspection Rules For Clinical Trials

Executive Summary

The European Commission has issued revised delegated legislation explaining new GMP requirements and inspection arrangements for investigational medicinal products that will come into play when the EU Clinical Trials Regulation kicks in.


Related Content

EU Finalizes GMP Rules, Inspection Procedures For Investigational And Finished Drugs
European Commission To ‘Explain And Discuss’ Contentious GMP Guide For ATMPs
Training For ‘Huge’ EU Clinical Trials Portal And Database On Track For 2017
European Commission Consults On New Clinical Trial Inspection And GMP Rules





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts